(NASDAQ: CLSD) Clearside Biomedical's forecast annual revenue growth rate of 58.37% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Clearside Biomedical's revenue in 2024 is $8,226,000.On average, 3 Wall Street analysts forecast CLSD's revenue for 2024 to be $288,124,712, with the lowest CLSD revenue forecast at $44,832,683, and the highest CLSD revenue forecast at $718,070,146. On average, 2 Wall Street analysts forecast CLSD's revenue for 2025 to be $1,099,521,560, with the lowest CLSD revenue forecast at $993,043,937, and the highest CLSD revenue forecast at $1,205,999,183.
In 2026, CLSD is forecast to generate $2,555,089,348 in revenue, with the lowest revenue forecast at $2,439,645,188 and the highest revenue forecast at $2,670,533,508.